Robert I. Misbin
-
- Diabetes Treatment and Management 6
- Nephrology top 5%
- Clinical Biochemistry top 5%
- Physiology top 10%
- Diet and metabolism studies 9
- Adipose Tissue and Metabolism 4
- Biochemistry top 10%
-
- Metabolism, Diabetes, and Cancer 15
-
- Pancreatic function and diabetes 9
-
- Diabetes and associated disorders 5
-
- Neuropeptides and Animal Physiology 4
-
- Palliative Care and End-of-Life Issues 4
- Co-authors
- Richard J. SantenE C AlmiraPeter W. StacpooleStephen H. CurryEloise HarmanThomas G. BaumgartnerAndrea J. PulkkinenThomas J. Merimee
- Journals
- Diabetes (9 papers)The Journal of Clinical Endocrinology & Metabolism (6 papers)Metabolism (5 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Robert I. Misbin
51 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 104
- Endocrinology, Diabetes and Metabolism 415
- Nephrology 110
- Clinical Biochemistry 96
- Physiology 229
- Biochemistry 50
Countries citing papers authored by Robert I. Misbin
This map shows the geographic impact of Robert I. Misbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert I. Misbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert I. Misbin more than expected).
Fields of papers citing papers by Robert I. Misbin
This network shows the impact of papers produced by Robert I. Misbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert I. Misbin. The network helps show where Robert I. Misbin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert I. Misbin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 0 | |
| 2 | 2007 | 8 | |
| 3 | 2004 | 135 | |
| 4 | 1997 | 74 | |
| 5 | 1996 | 7 | |
| 6 | 1991 | 34 | |
| 7 | 1989 | 3 | |
| 8 | 1987 | 32 | |
| 9 | 1985 | 10 | |
| 10 | 1984 | 3 | |
| 11 | 1984 | 12 | |
| 12 | 1983 | 8 | |
| 13 | 1983 | 6 | |
| 14 | 1981 | 9 | |
| 15 | 1981 | 19 | |
| 16 | 1980 | 2 | |
| 17 | 1980 | 8 | |
| 18 | 1979 | 27 | |
| 19 | 1978 | 21 | |
| 20 | 1972 | 9 |
About Robert I. Misbin
Robert I. Misbin is a scholar working on Endocrinology, Diabetes and Metabolism, Endocrine and Autonomic Systems, Nephrology, Physiology and Emergency Medicine, having authored 53 papers that have together received 1.3k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (15 papers), Diet and metabolism studies (9 papers), Pancreatic function and diabetes (9 papers), Diabetes Treatment and Management (6 papers), Diabetes and associated disorders (5 papers), Neuropeptides and Animal Physiology (4 papers), Palliative Care and End-of-Life Issues (4 papers) and Adipose Tissue and Metabolism (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (415 citations), Nephrology (110 citations), Clinical Biochemistry (96 citations), Physiology (229 citations) and Biochemistry (50 citations). Robert I. Misbin has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Richard J. Santen, E C Almira, Peter W. Stacpoole, Stephen H. Curry, Eloise Harman, Thomas G. Baumgartner, Andrea J. Pulkkinen, Thomas J. Merimee, Thomas D Mehl and DA Willard. Their work appears in journals such as Diabetes, The Journal of Clinical Endocrinology & Metabolism, Metabolism, Diabetes Care and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.